Your browser doesn't support javascript.
loading
Diastolic dysfunction in prediabetic male rats: Role of mitochondrial oxidative stress.
Koncsos, Gábor; Varga, Zoltán V; Baranyai, Tamás; Boengler, Kerstin; Rohrbach, Susanne; Li, Ling; Schlüter, Klaus-Dieter; Schreckenberg, Rolf; Radovits, Tamás; Oláh, Attila; Mátyás, Csaba; Lux, Árpád; Al-Khrasani, Mahmoud; Komlódi, Tímea; Bukosza, Nóra; Máthé, Domokos; Deres, László; Barteková, Monika; Rajtík, Tomás; Adameová, Adriana; Szigeti, Krisztián; Hamar, Péter; Helyes, Zsuzsanna; Tretter, László; Pacher, Pál; Merkely, Béla; Giricz, Zoltán; Schulz, Rainer; Ferdinandy, Péter.
Afiliação
  • Koncsos G; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Varga ZV; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary; Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
  • Baranyai T; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Boengler K; Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Giessen, Germany.
  • Rohrbach S; Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Giessen, Germany.
  • Li L; Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Giessen, Germany.
  • Schlüter KD; Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Giessen, Germany.
  • Schreckenberg R; Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Giessen, Germany.
  • Radovits T; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Oláh A; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Mátyás C; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Lux Á; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Al-Khrasani M; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Komlódi T; Department of Medical Biochemistry, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Bukosza N; Institute of Pathophysiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Máthé D; Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary; CROmed Translational Research Centers, Budapest, Hungary.
  • Deres L; 1st Department of Internal Medicine, Faculty of Medicine, University of Pécs, Pécs, Hungary.
  • Barteková M; Institute of Physiology, Faculty of Medicine, Comenius University in Bratislava, Slovakia; Institute for Heart Research, Slovak Academy of Sciences, Bratislava, Slovakia.
  • Rajtík T; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.
  • Adameová A; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University in Bratislava, Slovakia.
  • Szigeti K; Department of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Hamar P; Institute of Pathophysiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Helyes Z; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine and Szentágothai Research Centre & MTA-PTE NAP B Chronic Pain Research Group, University of Pécs, Pécs, Hungary; and.
  • Tretter L; Department of Medical Biochemistry, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
  • Pacher P; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary; Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland.
  • Merkely B; Heart and Vascular Center, Semmelweis University, Budapest, Hungary.
  • Giricz Z; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary; giricz.zoltan@med.semmelweis-univ.hu.
  • Schulz R; Institute of Physiology, Faculty of Medicine, Justus-Liebig University, Giessen, Germany.
  • Ferdinandy P; Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Am J Physiol Heart Circ Physiol ; 311(4): H927-H943, 2016 10 01.
Article em En | MEDLINE | ID: mdl-27521417
ABSTRACT
Although incidence and prevalence of prediabetes are increasing, little is known about its cardiac effects. Therefore, our aim was to investigate the effect of prediabetes on cardiac function and to characterize parameters and pathways associated with deteriorated cardiac performance. Long-Evans rats were fed with either control or high-fat chow for 21 wk and treated with a single low dose (20 mg/kg) of streptozotocin at week 4 High-fat and streptozotocin treatment induced prediabetes as characterized by slightly elevated fasting blood glucose, impaired glucose and insulin tolerance, increased visceral adipose tissue and plasma leptin levels, as well as sensory neuropathy. In prediabetic animals, a mild diastolic dysfunction was observed, the number of myocardial lipid droplets increased, and left ventricular mass and wall thickness were elevated; however, no molecular sign of fibrosis or cardiac hypertrophy was shown. In prediabetes, production of reactive oxygen species was elevated in subsarcolemmal mitochondria. Expression of mitofusin-2 was increased, while the phosphorylation of phospholamban and expression of Bcl-2/adenovirus E1B 19-kDa protein-interacting protein 3 (BNIP3, a marker of mitophagy) decreased. However, expression of other markers of cardiac auto- and mitophagy, mitochondrial dynamics, inflammation, heat shock proteins, Ca2+/calmodulin-dependent protein kinase II, mammalian target of rapamycin, or apoptotic pathways were unchanged in prediabetes. This is the first comprehensive analysis of cardiac effects of prediabetes indicating that mild diastolic dysfunction and cardiac hypertrophy are multifactorial phenomena that are associated with early changes in mitophagy, cardiac lipid accumulation, and elevated oxidative stress and that prediabetes-induced oxidative stress originates from the subsarcolemmal mitochondria.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Hipertrofia Ventricular Esquerda / Disfunção Ventricular Esquerda / Estresse Oxidativo / Diabetes Mellitus Experimental / Mitocôndrias Cardíacas Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Pré-Diabético / Hipertrofia Ventricular Esquerda / Disfunção Ventricular Esquerda / Estresse Oxidativo / Diabetes Mellitus Experimental / Mitocôndrias Cardíacas Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article